Star Health Insurance approves FY26 financials at 21st AGM
- Shareholders approved FY26 standalone financial statements at the 21st AGM
- Deepak Ramineedi was reappointed as a director after retiring by rotation
- Utpal Hemendra Sheth appointed as nominee director for Sitara Partners LLP
- The meeting was held via video conferencing on August 28, 2026

*this image is generated using AI for illustrative purposes only.
Star Health Insurance concluded its 21st Annual General Meeting on August 28, 2026, with shareholders approving the company’s standalone financial statements for FY26.
The meeting, chaired by Non-Executive Independent Director Rajeev Kher, was conducted via video conferencing from the company’s Chennai headquarters. Members also approved the reappointment of Deepak Ramineedi as a director and the appointment of Utpal Hemendra Sheth as a nominee director representing Sitara Partners LLP.
Key Resolutions
The board placed three items for consideration during the proceedings:
- Adoption of audited standalone financial statements for the fiscal year ended March 31, 2026
- Reappointment of Deepak Ramineedi (DIN: 07631768), who retired by rotation
- Appointment of Utpal Hemendra Sheth (DIN: 00081012) as a nominee director
Management Participation
Managing Director and CEO Anand Roy addressed members alongside other key executives. The board participants included Chief Marketing Officer Himanshu Walia, Chief Operating Officer Amitabh Jain, and CFO Niles Kambli.
Independent directors Rohit Bhasin and Anisha Motwani were present in their respective committee chair capacities. Secretarial auditors from Chitra, Lalitha & Associates and scrutinizer Mirza Ismail Irshad Ahmed oversaw the voting process.
Historical Stock Returns for Star Health Insurance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.15% | -0.35% | -3.13% | +23.20% | +31.82% | 0.0% |
How might the appointment of Utpal Hemendra Sheth as a nominee director for Sitara Partners LLP influence Star Health's strategic direction or potential M&A activities?
What specific growth initiatives or risk management strategies did CEO Anand Roy highlight during the AGM to address the competitive landscape in India's health insurance sector?
Given the approval of FY26 standalone financials, what are the projected revenue targets and profitability margins for FY27 amidst rising medical inflation?


































